• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用于癌症相关性视网膜病变的一种缓释地塞米松植入物。

A slow-release dexamethasone implant for cancer-associated retinopathy.

机构信息

Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

Ocular Oncology Service, Bascom Palmer Eye Institute and Sylvester Cancer Center, University of Miami, Miami, FL, USA.

出版信息

Arq Bras Oftalmol. 2023 Mar-Apr;86(2):171-174. doi: 10.5935/0004-2749.20230006.

DOI:10.5935/0004-2749.20230006
PMID:35170652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11892486/
Abstract

This case report aims to show the anatomical and functional results of a patient diagnosed as having cancer-associated retinopathy treated with a controlled-release dexamethasone implant (Ozurdex). Anatomical outcomes were assessed using spectral domain optical coherence tomography; and functional outcomes, by measuring visual acuity, microperimetry, and mutifocal electroretinography. The follow-up period was 1 year.

摘要

本病例报告旨在展示一位被诊断为患有癌症相关性视网膜病变的患者接受控释型地塞米松植入物（Ozurdex）治疗后的解剖和功能结果。使用谱域光学相干断层扫描评估解剖学结果；通过测量视力、微视野和多焦视网膜电图评估功能结果。随访时间为 1 年。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e292/11892486/f768dceeaf23/abo-86-02-20230006-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e292/11892486/389d141092bc/abo-86-02-20230006-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e292/11892486/f768dceeaf23/abo-86-02-20230006-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e292/11892486/389d141092bc/abo-86-02-20230006-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e292/11892486/f768dceeaf23/abo-86-02-20230006-g02.jpg

相似文献

1
A slow-release dexamethasone implant for cancer-associated retinopathy.用于癌症相关性视网膜病变的一种缓释地塞米松植入物。
Arq Bras Oftalmol. 2023 Mar-Apr;86(2):171-174. doi: 10.5935/0004-2749.20230006.
2
SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.玻璃体内注射Ozurdex®治疗视网膜静脉阻塞合并黄斑囊样水肿的频域光学相干断层扫描图像特征
Eur J Ophthalmol. 2011 Sep-Oct;21(5):631-6. doi: 10.5301/EJO.2011.7428.
3
Short-Term Assessment of Intravitreal Dexamethasone Implant Using Enhanced-Depth Image Optical Coherence Tomography and Optical Coherence Tomography Angiography in Patients with Retinal Vascular Diseases.应用改良深度成像光学相干断层扫描和光学相干断层扫描血管成像评估视网膜血管疾病患者玻璃体内植入地塞米松短期疗效。
Adv Ther. 2019 Feb;36(2):416-425. doi: 10.1007/s12325-018-0848-0. Epub 2018 Dec 18.
4
Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.玻璃体内注射地塞米松植入物（Ozurdex）对黄斑形态和功能的影响。
Retina. 2014 Feb;34(2):330-41. doi: 10.1097/IAE.0b013e31829f7495.
5
Monthly microperimetry (MP1) measurement of macular sensitivity after dexamethasone implantation (Ozurdex) in retinal vein occlusions.视网膜静脉阻塞患者接受地塞米松植入（Ozurdex）后黄斑敏感度的每月微视野检查（MP1）测量
Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):1873-82. doi: 10.1007/s00417-014-2897-7. Epub 2015 Jan 11.
6
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.玻璃体内注射地塞米松植入物治疗视网膜血管疾病所致难治性黄斑水肿：KKESH国际视网膜协作研究组的结果
Retina. 2016 Jan;36(1):131-6. doi: 10.1097/IAE.0000000000000616.
7
OZURDEX® (Dexamethasone Intravitreal Implant) 0.7 mg as Initial Therapy in Pseudophakic Patients With Diabetic Macular Edema, Macular Edema Following Retinal Vein Occlusion, and Noninfectious Posterior Segment Uveitis: A Case-Based Discussion.Ozurdex®（地塞米松玻璃体内植入剂）0.7毫克作为初始治疗用于假晶状体糖尿病性黄斑水肿、视网膜静脉阻塞后黄斑水肿及非感染性后段葡萄膜炎患者：基于病例的讨论
Retina. 2019 Jun;39 Suppl 1:S1-S28. doi: 10.1097/01.iae.0000574292.81105.b2.
8
The Structural and Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex) and Anti-VEGF Injection in Branched Retinal Vein Occlusion Patients by Optical Coherence Tomography Angiography Images Quantitation.光学相干断层扫描血管造影图像定量分析玻璃体内植入型地塞米松（Ozurdex）与抗 VEGF 注射治疗分支型视网膜静脉阻塞的结构和对比分析。
Semin Ophthalmol. 2021 Oct 3;36(7):475-481. doi: 10.1080/08820538.2021.1890146. Epub 2021 Apr 10.
9
SAFETY AND FEASIBILITY OF A NOVEL 25-GAUGE BIODEGRADABLE IMPLANT OF DEXAMETHASONE FOR TREATMENT OF MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION: A PHASE I CLINICAL TRIAL.一种新型25G可生物降解地塞米松植入物治疗视网膜静脉阻塞相关黄斑水肿的安全性和可行性：一项I期临床试验
Retin Cases Brief Rep. 2018;12(1):50-58. doi: 10.1097/ICB.0000000000000413.
10
Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.雷珠单抗与地塞米松植入物治疗视网膜分支静脉阻塞继发黄斑水肿的两年疗效
Optom Vis Sci. 2018 Dec;95(12):1149-1154. doi: 10.1097/OPX.0000000000001306.

引用本文的文献

1
Clinical Outcomes of Therapeutic Interventions for Autoimmune Retinopathy: A Meta-analysis and Systematic Review.自身免疫性视网膜病变治疗干预的临床结果：一项荟萃分析与系统评价
Ophthalmol Sci. 2024 Sep 12;5(1):100622. doi: 10.1016/j.xops.2024.100622. eCollection 2025 Jan-Feb.
2
Case report: Longitudinal evaluation and treatment of a melanoma-associated retinopathy patient.病例报告：一名黑色素瘤相关性视网膜病变患者的纵向评估与治疗
Front Med (Lausanne). 2024 Sep 10;11:1445180. doi: 10.3389/fmed.2024.1445180. eCollection 2024.
3
-TRPM1 autoantibody-positive unilateral melanoma associated retinopathy (MAR) triggered by immunotherapy recapitulates functional and structural details of -associated congenital stationary night blindness.

本文引用的文献

1
Immunopathogenesis of ophthalmological paraneoplastic syndromes: Recent findings.眼科副肿瘤综合征的免疫发病机制：最新发现
Adv Clin Exp Med. 2018 Oct;27(10):1431-1439. doi: 10.17219/acem/73860.
2
[Paraneoplastic Syndromes in Ophthalmology (French version of the article)].[眼科副肿瘤综合征（文章法文版）]
J Fr Ophtalmol. 2018 Jun;41(6):554-559. doi: 10.1016/j.jfo.2018.02.003. Epub 2018 Jun 9.
3
Improvements of visual function and outer retinal morphology following spontaneous regression of cancer in anti-recoverin cancer-associated retinopathy.
由免疫疗法引发的TRPM1自身抗体阳性单侧黑色素瘤相关性视网膜病变（MAR）重现了相关先天性静止性夜盲的功能和结构细节。
Am J Ophthalmol Case Rep. 2024 Jul 5;36:102098. doi: 10.1016/j.ajoc.2024.102098. eCollection 2024 Dec.
4
Case Report: Longitudinal Evaluation and Treatment of a Melanoma-Associated Retinopathy Patient.病例报告：一名黑色素瘤相关性视网膜病变患者的纵向评估与治疗
Res Sq. 2024 Jun 19:rs.3.rs-4595829. doi: 10.21203/rs.3.rs-4595829/v1.
5
Intravitreal Dexamethasone Implant in Autoimmune Retinopathy.玻璃体内注射地塞米松植入物治疗自身免疫性视网膜病变。
Case Rep Ophthalmol Med. 2023 Mar 31;2023:5670538. doi: 10.1155/2023/5670538. eCollection 2023.
抗恢复蛋白癌症相关性视网膜病变中癌症自发消退后视觉功能和视网膜外层形态的改善
Am J Ophthalmol Case Rep. 2017 Jan 6;5:137-140. doi: 10.1016/j.ajoc.2016.12.024. eCollection 2017 Apr.
4
Recovery of outer retinal laminations on optical coherence tomography after treatment of cancer associated retinopathy.癌症相关性视网膜病变治疗后光学相干断层扫描显示外层视网膜分层的恢复情况
Am J Ophthalmol Case Rep. 2017 Sep 1;8:11-13. doi: 10.1016/j.ajoc.2017.08.001. eCollection 2017 Dec.
5
Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy.副肿瘤性和非副肿瘤性自身免疫性视网膜病变患者的血清自身抗体谱分析
PLoS One. 2016 Dec 8;11(12):e0167909. doi: 10.1371/journal.pone.0167909. eCollection 2016.
6
Management of autoimmune retinopathies with immunosuppression.自身免疫性视网膜病变的免疫抑制治疗
Arch Ophthalmol. 2009 Apr;127(4):390-7. doi: 10.1001/archophthalmol.2009.24.
7
Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.与抗烯醇化酶抗体相关的副肿瘤性和自身免疫性视网膜病变的临床和电生理特征
Am J Ophthalmol. 2005 May;139(5):780-94. doi: 10.1016/j.ajo.2004.12.104.